Thyroid cancer is the most common endocrine cancer, affecting more people each year as detection rates continue to rise.

Microbiome diagnostics and AI are redefining early disease detection, emphasizing the gut's impact on health and the ...

Thyroid cancer is the most common endocrine cancer, affecting more people each year as detection rates continue to rise.

DELFI Diagnostics, Inc., developer of accessible blood-based, liquid biopsy tests that deliver a new way to enhance early cancer detection, today announced the appointment of Cindy Soriano as Chief ...

Thyroid cancer is the most common endocrine cancer, affecting more people each year as detection rates continue to rise.

The SleepFM model reveals how sleep analysis can predict disease risk, offering insights into sleep's role as a vital health ...

Detailed price information for Biomark Diagnostics Inc (BUX-CN) from The Globe and Mail including charting and trades.

Successful implementation requires modern healthcare infrastructure, including reliable electricity, high-speed internet ...

Expanding U.S. market access with an experienced technology investor and AI-driven growth strategistVancouver, British Columbia--(Newsfile Corp. - December 30, 2025) - BioMark Diagnostics Inc. (CSE: ...

VANCOUVER, BC, Dec. 31, 2025 /CNW/ -- The precision oncology market surged to $139.4 billion in 2025 and is racing toward $317.5 billion by 2035([1]) , driven by a fundamental shift in cancer ...

A blood-based liquid biopsy test detects early-onset colorectal cancer with strong diagnostic performance and high ...

DCGI releases classification of 77 medical devices related to oncology: Gireesh Babu, New Delhi Wednesday, January 7, 2026, 08:00 Hrs [IST] As part of its efforts to regulate the ...